OPTIMIZATION OF POST-ABORTION REHABILITATION AFTER EARLY PREGNANCY TERMINATION USING COMBINED ORAL CONTRACEPTIVES WITH FOLATES ACCORDING TO THE "QUICK START" SCHEME: HORMONAL AND REPRODUCTIVE EFFECTS
Keywords:
early pregnancy termination, post-abortion care, hormonal imbalance, adaptation, surgical methods, pharmacological methods, hormonal correction, folate-containing contraceptivesAbstract
Early pregnancy termination is a significant factor affecting women’s overall health and reproductive potential. Despite a decline in abortion rates in Uzbekistan, early termination still carries risks of infertility, hormonal disorders, and long-term complications. This study aimed to investigate hormonal status and adaptation following early abortion in order to identify optimal approaches to post-abortion care. A cohort of 100 women of reproductive age was examined using retrospective medical record analysis, hormonal profiling, clinical and biochemical tests, and ultrasound imaging. Findings demonstrated that early termination disrupts hormonal balance, prolongs adaptation, and may adversely affect fertility and subsequent pregnancy outcomes. Pharmacological methods were associated with fewer complications compared to surgical ones, while hormonal correction—particularly in combination with folate-containing contraceptives—proved effective in restoring balance and reducing adverse effects. The results highlight the need for individualized, hormone-oriented strategies in post-abortion rehabilitation and preconception care.
References
Алексюк МЮ, et al. Регуляторно-адаптационный потенциал после медикаментозного аборта. Фунд Мед Биол. 2017;2:37–39.
Алехина АГ. Влияние искусственного прерывания беременности на репродуктивные возможности женщин. Журнал акушерства и женских болезней. 2019;68(4):45–52.
Байкулова ТЮ, Петров ЮА. Беременность у первобеременных с абортивным анамнезом. Валеология. 2016;1:85–95.
Госкомстат РУз. О снижении числа абортов в Узбекистане. Ташкент: 2022. Доступно: https://stat.uz/ru/press-tsentr/novosti-goskomstata/22624-o-zbekistonda-homiladorlikni-to-xtatish-abort-lar-soni-kamaydi-2
Министерство здравоохранения РУз. Национальная стратегия репродуктивного здоровья. Ташкент: 2020.
American College of Obstetricians and Gynecologists. Access to postabortion contraception. Committee Opinion No. 833. Obstet Gynecol. 2021;138(2):e91–e95.
American College of Obstetricians and Gynecologists. Early pregnancy loss. Practice Bulletin No. 200. Obstet Gynecol. 2018;132(5):e197–e207.
Bayer HealthCare. SAFYRAL (drospirenone/ethinyl estradiol/levomefolate calcium) prescribing information. 2022.
Berer M, Henshaw SK. Global review of abortion incidence and mortality. Popul Rep. 2001;30(1):1–44.
Beyond safety: the 2022 WHO abortion guidelines. BMJ Glob Health. 2022;7(6):e009557. doi:10.1136/bmjgh-2022-009557.
Bridwell RE, et al. Post-abortion Complications: A Narrative Review for Clinicians. Cureus. 2022;14(10):e30323. doi:10.7759/cureus.30323.
National Institute for Health and Care Excellence. Abortion Care. NICE guideline NG140. London: NICE; 2019.
National Institutes of Health. Medical abortion. Office of Women's Health. 2018.
Pritchard J, McIntyre S. Hormonal stress response in reproductive health post-abortion. J Reprod Med. 2015;63(2):125–131.
Royal College of Obstetricians and Gynaecologists. Best Practice in Post-Abortion Contraception. London: RCOG; 2022.
Van Hylckama Vlieg A, et al. The venous thrombotic risk of oral contraceptives. BMJ. 2009;339:b2921. doi:10.1136/bmj.b2921.
Winikoff B, Dzuba IG. Extending outpatient medical abortion services through 70 days. Obstet Gynecol. 2012;120(5):1070–1076.
World Health Organization. Abortion care guideline. Geneva: WHO; 2022.
World Health Organization. Safe abortion: technical and policy guidance. Geneva: WHO; 2012.
World Health Organization. Unsafe abortion: global and regional estimates. Geneva: WHO; 2018.
